Cargando…

Factors associated with change in exacerbation frequency in COPD

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) can be categorized as having frequent (FE) or infrequent (IE) exacerbations depending on whether they respectively experience two or more, or one or zero exacerbations per year. Although most patients do not change category from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donaldson, Gavin C, Müllerova, Hanna, Locantore, Nicholas, Hurst, John R, Calverley, Peter MA, Vestbo, Jorgen, Anzueto, Antonio, Wedzicha, Jadwiga A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733814/ https://www.ncbi.nlm.nih.gov/pubmed/23899210 http://dx.doi.org/10.1186/1465-9921-14-79

Ejemplares similares

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

The causes and consequences of seasonal variation in COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2014)

Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD
por: Wilkinson, Tom M.A., et al.
Publicado: (2006)

Impact of the UK lockdown on people at risk of COPD
por: Donaldson, Gavin C., et al.
Publicado: (2021)

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease
por: Quint, Jennifer K, et al.
Publicado: (2012)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

The role of complement activation in COPD exacerbation recovery
por: Westwood, John-Paul, et al.
Publicado: (2016)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Exacerbation rate, health status and mortality in COPD – a review of potential interventions
por: Seemungal, Terence AR, et al.
Publicado: (2009)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
por: Calverley, Peter MA, et al.
Publicado: (2018)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Roflumilast: a review of its use in the treatment of COPD
por: Wedzicha, Jadwiga A, et al.
Publicado: (2016)

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(®) trial
por: Wise, Robert A, et al.
Publicado: (2018)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Prevention of COPD exacerbations: medications and other controversies
por: Vestbo, Jørgen, et al.
Publicado: (2015)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2008)

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
por: Wedzicha, Jadwiga A., et al.
Publicado: (2016)

A score to predict short-term risk of COPD exacerbations (SCOPEX)
por: Make, Barry J, et al.
Publicado: (2015)

Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD
por: Singh, R., et al.
Publicado: (2021)

Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations
por: Platé, Manuela, et al.
Publicado: (2014)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study
por: Hurst, John R, et al.
Publicado: (2010)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review
por: Hurst, John R, et al.
Publicado: (2009)

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes
por: Anzueto, A, et al.
Publicado: (2009)

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
por: Celli, Bartolome, et al.
Publicado: (2021)

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
por: Singh, Dave, et al.
Publicado: (2020)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset
por: Calverley, Peter M A, et al.
Publicado: (2022)

Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
por: Donaldson, Gavin C., et al.
Publicado: (2005)

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o8kka4esn9ao81pbd9uk0r8d8n